In people with type 2 diabetes, once-daily oral zenagamtide showed clinically meaningful and significant improvements in glycated haemoglobin (HbA1c) compared with placebo at three dose levels, study finds.
Find out more: spkl.io/60147ObcG
Thread
Nenhum Voo ainda